Biotronik has received European approval for the market release of its Evia HF-T pacemaker series, a cardiac resynchronization therapy-pacemaker (CRT-P) device approved for use in an MRI environment.

CT-induced cancer is always a concern when imaging younger patients, but an analysis of radiation risks has shown that young patients who undergo chest or abdominopelvic CT are more than 35 times more likely to die of their disease than develop a radiation-induced cancer, according to a study presented May 1 at the annual meeting of the American Roentgen Ray Society in Vancouver.

Although the federal Medicare incentives will be available through 2016, and Medicaid incentives through 2021, widespread gaps in readiness throughout the states illustrate the challenges physicians face in meeting the federal schedule for the incentive programs, according to an article published in the April edition of Health Affairs.

NEWTON, Mass.Everyone has their professional trials. Is yours your device alarm system? As more devices infiltrate hospitals, many are becoming too sensitive and triggering false-positive alarms that plague staff, said Mary L. White, RN, MBA, senior risk manager at Brigham & Womens Hospital in Boston, during an April 26 presentation at the 22nd Annual Conference on Cardiovascular Nursing sponsored by the American Heart Association (AHA).

An array of historical and global approaches provides viable models for developing local policies to promote and improve radiation safety among pediatric patients, according to a commentary published in the May issue of American Journal of Roentgenology.

McKesson has agreed to pay the U.S. more than $190 million to resolve claims that it violated the False Claims Act by reporting inflated pricing information for a large number of prescription drugs, causing Medicaid to overpay for those drugs, according to the U.S. Department of Justice.

Varian Medical Systems and Siemens Healthcare have signed a global partnership to provide diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery.

The fastest sales growth and heaviest competition in the EMR market is in products sold to physicians, particularly tools sold over the internet, according to healthcare market research firm Kalorama Information.